human
coronaviru
hcov
member
coronavirida
famili
caus
agent
upper
respiratori
tract
infect
atyp
pneumonia
despit
sever
epidem
outbreak
sever
occas
lack
antivir
drug
much
progress
made
regard
epitopebas
vaccin
design
hcov
studi
comput
approach
adopt
identifi
multiepitop
vaccin
candid
viru
could
suitabl
trigger
signific
immun
respons
sequenc
spike
protein
collect
protein
databas
analyz
silico
tool
identifi
immunogen
protein
cell
immun
b
cell
immun
check
peptid
ensur
capac
induc
humor
cellmedi
immun
peptid
sequenc
amino
acid
sequenc
ksstgfvyf
found
potenti
b
cell
cell
epitop
respect
furthermor
conserv
analysi
also
done
use
silico
tool
show
conserv
epitop
peptid
sequenc
could
interact
mani
human
leukocyt
antigen
hla
show
high
cumul
popul
coverag
rang
epitop
test
bind
hla
molecul
use
silico
dock
techniqu
verifi
bind
cleft
epitop
interact
allergen
epitop
also
evalu
comput
studi
design
epitopebas
peptid
vaccin
hcov
allow
us
determin
novel
peptid
antigen
target
spike
protein
intuit
ground
albeit
preliminari
result
thereof
requir
valid
vitro
vivo
experi
human
coronaviru
hcov
belong
coronavirida
famili
alphacoronaviru
compris
larg
group
envelop
positivesens
singlestrand
polyadenyl
rna
viru
consist
largest
known
viral
rna
genom
rang
kb
usual
coronavirus
classifi
three
group
group
iii
base
serolog
crossreact
classif
also
support
evolutionari
analysi
group
virus
anim
pathogen
includ
porcin
epidem
diarrhea
viru
felin
infecti
periton
viru
group
ii
virus
respons
domest
anim
pathogen
infect
final
group
iii
virus
respons
avian
speci
infect
howev
group
group
ii
virus
consid
hcov
protein
molecul
usual
contribut
structur
coronavirus
spike
envelop
e
membran
nucleocapsid
n
hcov
usual
caus
agent
upper
respiratori
tract
infect
also
caus
agent
atyp
pneumonia
first
identifi
peopl
republ
china
nowaday
submit
manuscript
wwwdovepresscom
oani
et
al
environment
resist
shown
virus
urgent
develop
effect
prevent
hcov
current
avail
treatment
vaccin
cure
hcov
infect
due
ever
rise
spread
viral
infect
develop
vaccin
antivir
drug
hcov
infect
crucial
novel
approach
integr
immunogenet
immunogenom
bioinformat
develop
vaccin
known
vaccinom
approach
use
address
develop
new
vaccin
present
convent
approach
vaccin
develop
reli
antigen
express
suffici
amount
vitro
cultur
model
howev
mani
antigen
express
suffici
may
good
candid
vaccin
convent
approach
possibl
control
differ
type
outbreak
viral
pathogen
recent
avian
swine
influenza
strain
due
timeconsum
develop
process
henc
rapid
silico
informaticsbas
approach
gain
much
popular
recent
advanc
sequenc
mani
pathogen
genom
protein
sequenc
databas
vaccinom
approach
alreadi
proven
essenti
combat
diseas
multipl
sclerosi
malaria
tumor
howev
method
vaccin
develop
usual
work
identif
human
leukocyt
antigen
hla
ligand
cell
epitop
specifi
select
potent
vaccin
candid
associ
transport
antigen
present
tap
molecul
allergen
assess
one
vital
step
develop
peptid
vaccin
provid
vaccin
human
bodi
detect
foreign
substanc
result
inflamm
occur
demonstr
allerg
reaction
predict
bcell
epitop
hydrophil
import
criterion
usual
beta
turn
region
assess
strengthen
possibl
vaccin
candid
therefor
present
studi
undertaken
design
epitopebas
peptid
vaccin
hcov
emc
use
vaccinom
approach
wet
lab
research
expect
valid
predict
flow
chart
summar
protocol
complet
epitop
predict
depict
figur
viralzon
databas
expasi
bioinformat
resourc
portal
use
select
hcov
associ
inform
includ
genu
famili
host
transmiss
diseas
genom
proteom
outer
membran
protein
spike
protein
sequenc
hcov
retriev
uniprotkb
databas
sequenc
store
fasta
format
analysi
analysi
evolutionari
diverg
membran
protein
hcov
phylogenet
tree
construct
use
multipl
sequenc
align
tool
antigen
protein
identif
vaxijen
server
predict
protect
antigen
subunit
vaccin
use
determin
potent
antigen
protein
use
default
paramet
server
determin
antigen
protein
netctl
server
use
identif
cell
epitop
predict
method
integr
peptid
major
histocompat
complex
class
mhci
bind
proteasom
c
termin
cleavag
tap
transport
effici
epitop
predict
restrict
mhci
supertyp
mhci
bind
proteasom
cleavag
perform
artifici
neural
network
weight
matrix
use
tap
transport
effici
paramet
use
analysi
set
threshold
maintain
sensit
specif
respect
allow
us
recruit
epitop
analysi
combin
algorithm
mhci
bind
tap
transport
effici
proteasom
cleavag
effici
select
predict
overal
score
tool
immun
epitop
databas
use
predict
mhci
bind
stabil
matrix
base
method
smm
use
calcul
halfmaxim
inhibitori
concentr
ic
valu
peptid
bind
mhci
molecul
differ
predict
method
bind
analysi
allel
select
length
set
predict
done
select
epitop
webbas
tool
use
predict
proteasom
cleavag
tap
transport
mhci
tool
combin
predictor
proteasom
process
tap
silico
epitopebas
peptid
vaccin
design
transport
mhci
bind
produc
overal
score
peptid
intrins
potenti
cell
epitop
smm
also
implement
predict
analysi
epitop
conserv
webbas
tool
iedb
analysi
resourc
use
popul
coverag
individu
epitop
select
iedb
popul
coverag
calcul
tool
analysi
resourc
use
allel
frequenc
interact
hla
allel
predict
popul
coverag
correspond
epitop
webbas
allerhunt
server
use
predict
allergen
propos
epitop
vaccin
develop
server
predict
allergen
combin
predict
use
integr
food
agricultur
organ
fao
world
health
organ
allergen
evalu
scheme
support
vector
machin
svm
pairwis
sequenc
similar
allerhunt
predict
allergen
well
nonallergen
high
oani
et
al
specif
make
allerhunt
use
program
allergen
crossreact
predict
molecular
dock
analysi
hla
allel
interact
design
threedimension
epitop
structur
dock
analysi
ksstgfvyf
epitop
subject
pepfold
webbas
server
structur
convers
order
analyz
interact
differ
hla
server
model
five
structur
propos
epitop
best
one
select
dock
analysi
ensur
bind
hla
molecul
predict
epitop
dock
studi
perform
use
molegro
virtual
docker
version
clc
bio
aarhu
denmark
hlab
predict
potenti
immunogen
epitop
given
protein
sequenc
may
significantli
reduc
wet
lab
effort
need
discov
epitop
requir
design
vaccin
immunodiagnost
aim
predict
b
cell
epitop
find
potenti
antigen
would
interact
b
lymphocyt
initi
immunorespons
tool
iedb
use
identifi
b
cell
antigen
includ
kolaskar
tongaonkar
antigen
scale
emini
surfac
access
predict
karplu
schulz
flexibl
predict
bepipr
linear
epitop
predict
analysi
chou
fasman
beta
turn
predict
tool
use
antigen
part
protein
belong
beta
turn
region
total
outer
membran
protein
spike
protein
sequenc
differ
variant
belong
five
type
emc
hcov
retriev
uniprotkb
databas
sequenc
subject
multipl
sequenc
align
order
construct
phylogenet
tree
figur
phylogram
show
evolutionari
diverg
among
differ
strain
hcov
vaxijen
server
assess
retriev
protein
sequenc
order
find
potent
antigen
protein
uniprotkb
id
select
potent
antigen
protein
highest
total
predict
score
protein
use
analysi
preselect
environ
netctl
server
predict
potent
cell
epitop
select
protein
sequenc
base
high
combinatori
score
five
best
epitop
tabl
select
analysi
mhci
bind
predict
run
smm
predict
wide
rang
mhci
allel
interact
five
cell
epitop
mhci
allel
epitop
show
higher
affin
ic
nm
select
analysi
tabl
mhci
process
proteasom
cleavagetap
transport
mhci
combin
predictor
predict
overal
score
peptid
intrins
potenti
cell
epitop
protein
sequenc
proteasom
complex
cleav
peptid
bond
thu
convert
protein
peptid
peptid
molecul
proteasom
cleavag
associ
classi
mhc
molecul
peptidemhc
molecul
transport
cell
membran
present
helper
cell
higher
overal
score
peptid
denot
higher
process
capabl
tabl
among
five
cell
epitop
mer
epitop
ksstgfvyf
found
interact
mhc
tabl
iedb
conserv
analysi
tool
analyz
conserv
predict
epitop
shown
tabl
popul
coverag
predict
epitop
depict
figur
sequencebas
allergen
predict
precis
calcul
use
allerhunt
tool
predict
queri
epitop
allergen
score
sensit
specif
predict
epitop
bound
groov
hlab
energi
kcalmol
dock
interact
visual
pymol
molecular
graphic
system
version
llc
portland
usa
shown
figur
predict
amino
acid
scalebas
method
identif
potenti
bcell
epitop
accord
procedur
use
differ
analysi
method
predict
continu
b
cell
epitop
kolaskar
tongaonkar
antigen
predict
method
analyz
antigen
basi
physiochem
properti
amino
acid
abund
experiment
known
epitop
averag
antigen
propens
protein
maximum
minimum
antigen
determin
threshold
protein
valu
greater
potenti
antigen
determin
found
seven
epitop
satisfi
threshold
valu
set
prior
analysi
potenti
express
b
cell
respons
result
summar
tabl
figur
potent
b
cell
epitop
must
surfac
access
henc
emini
surfac
access
predict
obtain
region
amino
acid
residu
access
describ
figur
tabl
beta
turn
often
access
consider
hydrophil
natur
two
properti
antigen
tabl
five
potenti
cell
epitop
along
interact
mhci
allel
total
process
score
epitop
conserv
result
interact
mhci
allel
affin
nm
total
score
proteasom
score
tap
score
mhci
score
process
score
reason
chou
fasman
betaturn
predict
done
region
approxim
consid
region
figur
experiment
evid
found
flexibl
peptid
correl
antigen
henc
karplu
schulz
flexibl
predict
method
implement
predict
method
region
found
flexibl
figur
final
launch
bepipr
linear
epitop
predict
tool
program
base
hidden
markov
model
best
singl
method
predict
linear
bcell
epitop
result
analysi
method
summar
figur
tabl
crossreferenc
data
predict
peptid
sequenc
amino
acid
capabl
induc
desir
immun
respons
b
cell
epitop
etc
alreadi
suggest
though
epitopebas
vaccin
design
becom
familiar
concept
case
hcov
yet
much
work
done
hcov
rna
viru
tend
mutat
frequent
dna
virus
type
mutat
mostli
occur
outer
membran
protein
ie
spike
protein
type
mutat
increas
sustain
hcov
ensur
escap
cellmedi
humor
immun
respons
despit
spike
protein
potenti
target
vaccin
design
abil
induc
faster
longerterm
mucos
immun
respons
protein
reason
gain
much
popular
research
aspect
univers
hcov
vaccin
need
design
order
overcom
advers
effect
viral
infect
present
vaccin
mostli
base
b
cell
immun
recent
vaccin
base
cell
epitop
encourag
host
gener
strong
immun
respons
cell
infect
cell
time
due
antigen
drift
foreign
particl
escap
antibodi
memori
respons
howev
cell
immun
respons
often
provid
longlast
immun
predict
b
cell
cell
epitop
confer
immun
differ
way
recent
studi
hcov
repres
cell
epitop
want
express
greater
find
sever
criteria
need
fulfil
vaccin
candid
epitop
predict
epitop
fulfil
criteria
initi
criterion
conserv
epitop
measur
iedb
conserv
analysi
tool
among
tabl
kolaskar
tongaonkar
antigen
analysi
number
start
posit
end
posit
peptid
peptid
length
clcpvpglk
stgfvyfn
dvncngi
hnsvadv
nlksgvivfktlqydvlfycsnsssgvldtt
pfgpssqpyycfin
tthvstfvgilpptvreivvart
develop
new
vaccin
time
fashion
crucial
defend
ever
rise
global
burden
diseas
advanc
sequencebas
oani
et
al
five
potenti
cell
epitop
possess
conserv
also
found
similar
conserv
b
cell
epitop
conserv
epitop
ksstgfvyf
epitop
possess
highest
amount
interact
hla
allel
recent
studi
show
highli
conserv
sequenc
rna
direct
rna
polymeras
hcov
nevertheless
discoveri
spike
protein
conserv
among
spike
protein
drawn
much
attent
consid
epitop
candid
vaccin
develop
popul
coverag
anoth
import
factor
develop
vaccin
predict
epitop
cumul
percentag
popul
coverag
measur
found
highest
popul
coverag
south
ireland
follow
itali
north
america
coverag
respect
hcov
first
found
europ
henc
also
observ
overal
coverag
europ
found
oceania
region
cover
also
record
kong
year
viru
caus
hospit
per
popul
age
year
howev
allergen
one
promin
obstacl
vaccin
develop
today
vaccin
stimul
immun
system
allerg
reaction
induct
type
helper
cell
immunoglobulin
e
ige
allerhunt
score
valu
probabl
particular
sequenc
crossreact
allergen
howev
threshold
predict
allergen
crossreact
adjust
sequenc
predict
crossreact
allergen
probabl
propos
epitop
allergen
score
thu
consid
nonallergen
accord
faowho
evalu
scheme
allergen
predict
sequenc
potenti
allergen
either
ident
least
six
contigu
amino
acid
percent
sequenc
ident
window
amino
acid
compar
known
allergen
henc
queri
epitop
silico
epitopebas
peptid
vaccin
design
fulfil
criteria
faowho
evalu
scheme
allergen
predict
classifi
scheme
nonallergen
howev
predict
silico
result
base
dilig
analysi
sequenc
variou
immun
databas
type
studi
recent
receiv
experiment
valid
reason
suggest
propos
epitop
would
abl
trigger
efficaci
immun
respons
peptid
vaccin
vivo
studi
shown
integr
comput
approach
could
use
predict
vaccin
candid
pathogen
hcov
previous
describ
valid
procedur
way
silico
studi
save
time
cost
research
guid
experiment
work
higher
probabl
find
desir
solut
fewer
trial
error
repeat
assay
glk
tgsdvncngyqhn
n
vdn
sssgvl
submit
manuscript
http
wwwdovepresscomdrugdesigndevelopmentandtherapyjourn
drug
design
develop
therapi
intern
peerreview
openaccess
journal
span
spectrum
drug
design
develop
clinic
applic
clinic
outcom
patient
safeti
program
develop
effect
safe
sustain
use
medicin
featur
journal
also
accept
index
pubm
central
manuscript
manag
system
complet
onlin
includ
quick
fair
peerreview
system
easi
use
visit
http
wwwdovepresscomtestimonialsphp
read
real
quot
publish
author
